← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Amunix Operating, Inc.
Mountain View, CA
$2,372,146
Total funding
5
Grants
Funding over time
peak $1.2M · FY2007–12$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$2,372,146 · 5
By mechanism
R44$2,006,049 · 2
R43$366,097 · 3
Investigators at Amunix Operating, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Glycine rich sequences with pharmacokinetic enhancing properties of PEG polymers$668,435
R44 · FY2008 · GM
Targeting toxins to tumors using microproteins$531,863
R44 · FY2008 · CA
Targeting toxins to tumors using microproteins$463,261
R44 · FY2009 · CA
Glycine rich sequences with pharmacokinetic enhancing properties of PEG polymers$342,490
R44 · FY2009 · GM
XTENylation of enfuvirtide to generate a bio-better product with improved dosing$157,550
R43 · FY2012 · AI
Drug binding microprotein domains for targeted delivery of cytotoxic drugs$108,284
R43 · FY2007 · CA
Glycine rich sequences with pharmacokinetic enhancing properties of PEG polymers$100,263
R43 · FY2007 · GM